Making it personal: Neoantigen vaccines in metastatic melanoma Journal Article


Authors: Hellmann, M. D.; Snyder, A.
Article Title: Making it personal: Neoantigen vaccines in metastatic melanoma
Abstract: Somatic mutations in cancer can be translated into peptides, termed neoantigens, which can be recognized by the immune system as “foreign” epitopes. Two recent studies in Nature (Sahin et al., 2017; Ott et al., 2017) examine the effects of neoantigen vaccines on patients with stage III or IV melanoma and demonstrate immunogenicity and intriguing clinical safety and efficacy data in phase I studies. © 2017 Elsevier Inc.
Journal Title: Immunity
Volume: 47
Issue: 2
ISSN: 1074-7613
Publisher: Cell Press  
Date Published: 2017-08-15
Start Page: 221
End Page: 223
Language: English
DOI: 10.1016/j.immuni.2017.08.001
PROVIDER: scopus
PUBMED: 28813655
DOI/URL:
Notes: Short Survey -- Export Date: 5 September 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann